Finland· FI-REL-REL48997
Cepedex
A deksmedetomidiini product containing dexmedetomidine hydrochloride, registered in Finland by CP-Pharma Handelsgesellschaft mbH. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Dexmedetomidine hydrochloride is registered in 2 of 19 countries.
Countries holding a registration under ATC QN05CM18 (deksmedetomidiini), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Dexmedetomidine hydrochloride · ATC QN05CM18
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Dexmedetomidine hydrochloride
- Manufacturer
- CP-Pharma Handelsgesellschaft mbH
- Country
- Finland (FI)
- ATC code
- QN05CM18
- ATC class
- Deksmedetomidiini
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexmedetomidine hydrochloride in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDexmedetomidineAccord Healthcare Inc.
- CzechiaDEXDOROrion Corporation, Espoo
- BelgiumDexdor 100 µgOrion
- SpainDEXDOR 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONOrion Corporation
- United KingdomDexdor 1mg/10ml concentrate for solution for infusion vialsOrion Pharma (UK) Ltd
- CanadaDEXDOMITORORION CORPORATION
- SwedenDexdor 100 mikrogram/ml Koncentrat till infusionsvätska, lösningOrion Corporation
- NetherlandsDexdor 100 micrograms/ml, concentraat voor oplossing voor infusieOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dexmedetomidin Altan, Dexmedetomidin Altan Pharmaceuticals, S.A.
- Belgium · Dexmedetomidine A.Forall, Dexmedetomidine Baxter
- Bulgaria · Dexmedetomidine Ever Valinject, Dexmedetomidine Kalceks
- Cyprus · Dexmedetomidine Baxter, Dexmedetomidine Ever Valinject
- Czechia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma
- Germany · Dexmedetomidin B. Braun, Dexmedetomidin Baxter
- Denmark · Dexmedetomidin Kalceks, Dexmedetomidin Viatris
- Estonia · Dexmedetomidine Auxilia, Dexmedetomidine Kabi
- Spain · Dexmedetomidina Altan, Dexmedetomidina B. Braun
- France · Dexmedetomidine Altan, Dexmedetomidine Ever Pharma
- United Kingdom (Northern Ireland) · Dexmedetomidine 100 Micrograms/Ml Concentrate For Solution For Infusion, Dexmedetomidine Altan Pharma
- Greece · Dexmedetomidine /Kabi, Dexmedetomidine Ariti
- Croatia · Deksmedetomidin Kabi, Deksmedetomidin Kalceks
- Hungary · Dexmedetomidin Ever Pharma, Dexmedetomidine Kabi
- Ireland · Dexmedetomidine As Kalceks, Dexmedetomidine B. Braun
- Iceland · Dexdor, Dexmedetomidine Rph Pharma
- Italy · Dexmedetomidina Galenica Senese, Dexmedetomidina Hikma
- Liechtenstein · Dexdor
- Lithuania · Dexmedetomidine Kabi, Dexmedetomidine Kalceks
- Luxembourg · Dexmedetomidine Baxter, Dexmedetomidine Kabi
- Latvia · Dexmedetomidine Kalceks, Dexmedetomidine Pharmidea
- Malta · Dexmedetomidine Ever Valinject
- Netherlands · Dexmedetomidine Altan Pharmaceuticals, S.A., Dexmedetomidine B. Braun
- Norway · Dexdor, Dexmedetomidine B. Braun
- Poland · Dexmedetomidine Ever Pharma, Dexmedetomidine Farmak
- Portugal · Dexmedetomidina A.Forall, Dexmedetomidina Acure
- Romania · Dexmedetomidină Kabi, Dexmedetomidină Kalceks
- Sweden · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
- Slovenia · Deksmedetomidin Kalceks, Deksmedetomidin Viatris
- Slovakia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0b4618d-d8c7-46bf-8176-19359b9a8a12 GET /v1/drugs/b0b4618d-d8c7-46bf-8176-19359b9a8a12?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "0.5 mg/ml",
"atc_label": "Deksmedetomidiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/2/16/200/004-007",
"fimea_rel_id": "REL48997",
"authorised_at": "2016-12-13"
}See everything about dexmedetomidine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.